Actively Recruiting
Efficacy of Ultrasound-Guided Tri-Directional Needle Knife Release for Treating Trigger Finger A Minimally Invasive Procedure Study
Led by Mohamed Maher Ismail Ahmed Elashmawy · Updated on 2025-01-27
46
Participants Needed
1
Research Sites
40 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the safety and effectiveness of an ultrasound-guided tri-directional needle knife release procedure for treating patients with trigger finger, particularly those who have not responded to conservative treatments. Trigger finger is caused by thickening of the A1 pulley in the finger, which leads to pain, stiffness, and limited hand function. This trial focuses on comparing this minimally invasive procedure to conventional approaches for improving hand function and reducing pain. The treatment involves a precise ultrasound-guided procedure using a tri-directional needle knife to release the affected tissue. Local anesthesia with 3-5 ml of 1% lidocaine and 0.25% bupivacaine is used to ensure patient comfort. Real-time imaging is performed using the Sonosite M-Turbo Ultrasound Machine with a linear probe to guide the procedure accurately and safely. The goal is to minimize risks while improving outcomes. Participants will be monitored over six months for improvements in hand and finger function, reduction in pain based on a visual analog scale, and overall patient satisfaction. Researchers will assess finger mobility and pain scores post-procedure to evaluate recovery and effectiveness. The study requires compliance with follow-up visits and assessments to track progress and ensure safety throughout the study period.
CONDITIONS
Official Title
Efficacy of Ultrasound-Guided Needle Knife Release for Trigger Finger
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Idiopathic trigger finger at the A1 pulley
- Trigger finger of Green's grades II, III, or IV (moderate to severe)
- Symptoms lasting at least three months despite conservative treatments
- Ability to provide informed consent and comply with follow-up requirements
You will not qualify if you...
- Secondary trigger finger caused by diabetes mellitus, rheumatoid arthritis, gout, hypothyroidism, amyloidosis, or sarcoidosis
- Trigger finger of Green's grade I
- Previous surgical intervention on the affected finger
- Allergy or contraindication to local anesthetics
- Pregnancy or lactation
- Inability to comply with follow-up assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35516
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here